Navigation Links
Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America
Date:10/6/2011

MOUNTAIN VIEW, Calif. and BARCELONA, Spain, Oct. 6, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer International, S.A., announced today that they entered into a commercial partnership for Adasuve™ (Staccato® loxapine).  ADASUVE is Alexza's lead program, based on the company's proprietary technology, the Staccato system.  Grupo Ferrer is a leading pharmaceutical company in Europe with extensive operations in the Americas, and will be Alexza's partner in the registration, distribution and promotion of ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries.  Alexza plans to file the ADASUVE Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) in the second half of 2011.  ADASUVE is being developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.

"The treatment of agitation in patients with schizophrenia or bipolar disease continues to evolve in the field of psychiatry, and we believe that ADASUVE could represent an important new therapeutic option for these patients," said Thomas B. King, Alexza's President and CEO.  "Given Grupo Ferrer's extensive experience registering and selling specialty pharmaceuticals in Europe and Latin America, and their ability to share our longer-term vision for ADASUVE, we believe they represent an ideal multi-region partner for Alexza as we execute our global commercialization strategy."

"We welcome the opportunity to bring this innovative technology to our markets," said Mr. Jordi Ramentol, CEO of Grupo Ferrer.  "ADASUVE fits perfectly into our specialty pharmaceutical portfolio.  We strongly believe that the unique therapeutic benefits ADASUVE provides will capture physicians' and patients' interest, and establish it as an important new too
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
2. Alexza Announces Adasuve™ (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012
3. Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA
4. Alexza to Announce 2011 Second Quarter Financial Results on Monday, August 8, 2011
5. Alexza Reports 2011 First Quarter Financial Results and Provides Business Update
6. Alexza to Present at the MDB Bright Lights Conference 2011
7. Alexza Prices $16.1 Million Registered Direct Offering
8. Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
9. Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
10. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
11. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 Amgen (NASDAQ: AMGN ) ... 3, global, randomized, placebo-controlled trials evaluating AMG 416, ... hyperparathyroidism (SHPT) in patients with chronic kidney disease ... endpoint, demonstrating that a greater proportion of patients ... than 30 percent reduction in parathyroid hormone (PTH) ...
(Date:5/28/2015)... and HOUSTON , May 28, 2015 /PRNewswire/ ... today reported financial results for the second quarter and three ... otherwise, are expressed in Canadian dollars and in accordance with ... ESSA recorded a net loss of $5.9 ... March 31, 2015 (Q2-2015), compared to a net loss of ...
(Date:5/28/2015)... , May 28, 2015  IRIDEX Corporation (NASDAQ: IRIX ... Officer James H. Mackaness is scheduled to present ... at 9:00 am PT in Los Angeles ... may be accessed on the Event Calendar of the Investors ... of the webcast will be available shortly after the conclusion ...
Breaking Medicine Technology:Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... Oct. 5 Osseon Therapeutics, Inc. announced its ... North American Spine Society,s (NASS) annual meeting in ... facilitate treatment of vertebral compression fractures (VCFs) that ... fibrotic metastases.  The Osseoflex DR Steerable Bone Drill ...
... SUNNYVALE, Calif., Oct. 5 Accuray Incorporated (Nasdaq: ... of radiosurgery, announced today that the company was awarded a ... U.S. Government to be used toward further development of a ... grant will fund the development of a next generation, compact ...
Cached Medicine Technology:Osseon® Therapeutics Introduces New Osseoflex® DR Steerable Bone Drill 2Accuray Awarded $1 Million Grant by U.S. Government 2Accuray Awarded $1 Million Grant by U.S. Government 3
(Date:5/29/2015)... York (PRWEB) May 29, 2015 World ... patented products, announces that it has signed a 10 ... technology patent that aims to let people learn about ... in real time. , "This is an exciting day ... " said Scott J. Cooper, CEO and Creative Director ...
(Date:5/29/2015)... New York, NY (PRWEB) May 29, 2015 ... readers on the “beauty of protection”. Skin Health ... through USA Today within the markets of New York, ... reach an estimated 750,000 readers. Its digital counterpart will ... online content hubs. To read more the Skin Health ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... provides comprehensive information on the therapeutic development for ... of muscles in the body, leading to many ... pipelines by identifying new targets and MOAs to ... H1 2015 pipeline review of Axillary Hyperhidrosis with ...
(Date:5/29/2015)... Hollywood, Florida (PRWEB) May 29, 2015 ... and Bodybuilding.com teamed up to create an all new, ... supplements are a formulated with the latest and greatest, ... researched and proven to be effective. The 24/7 Series ... runners, to cross-fitters and even the casual fitness enthusiasts. ...
(Date:5/29/2015)... The annual aesthetic meeting, put on by the American ... from May 14-19th. This global event sets a gold ... world; dedicating itself exclusively to cosmetic medicine. Dr. Paul ... to attend this year’s meeting. , Among the classes ... given the honor of sitting at the presenter’s table during ...
Breaking Medicine News(10 mins):Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3
... choose to decorate the,Christmas tree, light the menorah, or ... can be an extremely stressful time for,couples in inter-faith ... to celebrate can strain your relationship and,lead to conflict ... on your religious backgrounds and level of dedication to ...
... The American Academy,of Orthopaedic Surgeons (AAOS) has approved and ... Carpal Tunnel Syndrome.", "Carpal Tunnel Syndrome, otherwise known ... upper extremity. It affects up to ten percent of,the ... thought to be caused,by increased pressure on the median ...
... of its commitment to providing the industry,s most aggressive defense, The ... liability in the U.S., is rolling out litigation education retreats for ... , ... Napa, Calif. (Vocus) October 27, 2008 -- As ...
... systems for HH-60M Black Hawk ... helicopter, ... largest air medical transportation company in the,world, today announced its Products Division ... Company for production of 48,HH-60M Black Hawk Multi-Mission Medevac Interior Systems. Production ...
... October 27, 2008 Is schizophrenia a disorder of ... for many years was that schizophrenia was a glutamate ... as well. The study by Karlsson et al., ... Psychiatry , reinforces this point with new data about ...
... Digital ID for Travelers Makes Doctor Visits Abroad Even ... a global health and,safety services company, today announced the ... card. My Digital ID enables HTH,members to access all ... mobile phone. Global travelers can rely on direct access ...
Cached Medicine News:Health News:He's Jewish, I'm Catholic, It's December. Now What? 2Health News:AAOS Issues New Treatment Guidelines for Carpal Tunnel Syndrome 2Health News:The Doctors Company Launches Litigation Education Retreats to Assist Physicians Involved in Medical Litigation 2Health News:Air Methods Receives $17 Million Contract from Sikorsky Aircraft Company 2Health News:Glutamate: Too much of a good thing in schizophrenia? 2Health News:HTH Worldwide Unveils First Digital Healthcare Card 2
... self-adjusting adaptability to fit almost every operating ... angling at the sit of fixation to ... it to be titled to any position ... a simple adjustment of the 3/D Swinger ...
Inquire...
Stainless steel construction to withstand sterilization modalities (EtO, Steris, and Sterrad)...
Stainless steel construction to withstand sterilization modalities (EtO, Steris, and Sterrad) Wide angle of view...
Medicine Products: